View all veterinary jobs
Krka says Robexera injectable acts within an hour, has a 24-hour duration and that its high COX-2 selectivity reduces wider systemic impact.1
The company says that in cats, the perioperative case is particularly strong, pointing to research which it says showed robenacoxib to have the best proven safety profile in cats of all NSAIDs.1
Krka adds that it is also highly effective in reducing post-operative pain, with evidence of superior efficacy to meloxicam,2 and a proven anaesthetic-sparing effect during feline surgery.3
Will Ridgway, Head of Animal Health at Krka UK, said: “Practices want product assurance and commercial value. As a bioequivalent to the originator product,4 Robexera injectable delivers both."
https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_3090863.PDF
References
Krka says Prazemo is the first generic to offer this combination of actives in this format, and is bioequivalent to the originator product.
Prazemo is available in three dosage strengths for different cat weights and can be used from 8 weeks of age and during pregnancy and lactation.
For cats that also require ectoparasiticide treatment, it can be used alongside a mono-isoxazoline (fluralaner) treatment.
Will Ridgway, Head of Animal Health at Krka UK, said: "Prazemo strengthens our feline parasiticide portfolio with an effective spot-on solution that veterinary practices can be confident delivers affordability combined with Krka’s high standards of product efficacy and supply chain control."
For more information, email: animalhealth.uk@krka.biz
Liberty (pictured) was nominated for her calm and reassuring presence and her ability to make every client feel heard and cared for.
One of her nominators said, “Liberty is the heartbeat of Poplar Vets.
"Her professionalism and empathy set the standard for our whole practice, and her calm, reassuring presence makes every client feel heard, understood and cared for.
"She has an unwavering willingness to go above and beyond, often stepping in without hesitation to keep the practice running smoothly no matter how busy or challenging the day.
"Liberty is the glue that holds our team together and a true hero in every sense of the word.”
Galedin Vets in Galashiels was awarded Reception Team of the Year.
Victoria Cuthbert nominated the reception team at Galedin, describing them as “just phenomenal.”
She explained how, despite some tough times, the team has remained dependable, positive and supportive, always looking after clients and colleagues with a smile.
One team member even gave up her own time to create a beautiful garden space outside the practice where staff can relax and unwind.
Victoria added “They keep everything running smoothly day after day and we’d be lost without them.”
Runners-up for the team award went to the Graylands Cat Clinic team in Horsham and Vets for Pets Chester Caldy.
Runners up for the individual award went to Alicia Armstrong of Vets for Pets Leeds Colton and Sue Gear of Tamar Vets, Bude.
Linda Buckle, Country Brand Manager at KRKA UK said: “Receptionists really are the hub of every practice
“They’re the friendly face clients come to know and trust and the vital link that keeps the whole practice running smoothly. It’s a demanding role that deserves more recognition and these awards are our way of saying thank you for everything they do.”
The winning entries received a trophy for their reception areas and gift vouchers to celebrate their success and hard work.
The three factsheet chapters cover understanding OA, creating a management plan and supporting pets and their owners.
Krka says each section is grounded in evidence-based approaches and was shaped by Professor Carmichael’s extensive knowledge of the pathogenesis of pain in patients with OA and experience in the diagnosis, contextualised treatment, and long-term care of patients with OA.
The resources encourage veterinary teams to adapt their approach to the needs of each case - supporting a flexible, patient-centred mindset in everyday consults.
Stuart said: “What works is the thing that works best for the dog, the owner and the practice in that moment.
“And part of the art is trying to get that right rather than being dogmatic about a certain type of treatment.”
Renzo Di Florio, Krka’s Technical Veterinary Adviser, said: “In first-opinion practice, consult time is limited and there’s a lot to cover.
"These factsheets bring together expert advice in a format that’s quick to reference and easy to apply in consults.
"They’re designed to help vets feel more confident in their approach to OA, especially when time is tight.”
To further support veterinary professionals in managing OA, Professor Carmichael has delivered a webinar, available here: https://membership.elearning.vet/rethinking-canine-oa-login.
He and Renzo will also be presenting together at the London Vet Show this November, delivering a session focused on osteoarthritis in practice on Thursday 20th November at 14.00 in Exhibitor Showcase Theatre 2.
The OA factsheets are available here: https://www.krka.co.uk/veterinary-knowledge-hub/
Designed to help veterinary teams make clearer, more confident clinical decisions, the flowchart provides a step-by-step approach to diagnosing and managing ear disease in dogs and cats.
Renzo Di Florio, Technical Veterinary Adviser at Krka UK, said: “It takes you through each step, from diagnosis to treatment and long-term management, including identifying cases that might benefit from referral.
"It can also help practices to develop an otitis externa management plan protocol that’s useful for the whole team, and that’s practical and easy to integrate into existing workflows.”
One of the main messages in the flowchart is the central role of cytology in otitis management.
Tim said: “Cytology is essential to assess the level of inflammation and detect the presence of bacteria or Malassezia.
"This helps clinicians make informed decisions about whether antibiotics are truly needed.
"In contrast, culture and sensitivity testing can be misleading when used to guide topical therapy.”
https://www.krka.co.uk/veterinary-knowledge-hub
Once again, there are awards for both individual receptionists and reception teams
The winners will receive trophies and Amazon vouchers.
Emma Coole, Account Manager for the South West of the UK at KRKA UK said: "Reception teams are the glue that holds a busy practice together.
"They’re juggling phone calls, managing appointments, supporting worried pet owners at the front desk - and doing it all with empathy and professionalism.
"I regularly see and hear first-hand how much the wider vet practice depends on their calm, capable presence.
"These awards are a chance to recognise the people who make that happen every single day.”
Practices are encouraged to nominate receptionists or teams who make a real difference – whether through kindness, a cool head under pressure or simply keeping everything running smoothly.
Nominations are now open and will close on Friday 26th September 2025.
Winners and runners-up will be announced on Wednesday 1st October 2025.
To submit a nomination or learn more about the awards, visit https://bit.ly/receptionist-team-hero-awards-2025
Krka says Arocenia provides fast, broad-spectrum anti-emetic efficacy with a 24-hour duration of action following a single daily dose.
It can be administered intravenously or subcutaneously and is supplied in 20 ml multi-dose vials, allowing up to 40 punctures per vial and a 60-day open vial shelf life.
Renzo Di Florio, Krka’s Technical Veterinary Adviser, commented “Vomiting is one of the most common presenting signs in small animal practice, and maropitant is a medication you’ll find on just about every vet’s dispensary shelf. With Arocenia, we’re adding a cost-effective formulation to the available options.”
https://www.krka.co.uk//products/our-products/animal-health/arocenia-10mgml-solution-for-injection
Topics include applying the principles of antimicrobial stewardship (AMS), making confident diagnostic and prescribing decisions, and managing client expectations around antibiotic use within practice.
In the first episode, Tim explores how to apply the principles of AMS in the consulting room, starting with recognising when antibiotics are genuinely needed.
He explores the role of clinical signs and cytology in guiding diagnosis and treatment decisions, while also emphasising the risks of unnecessary prescribing.
The discussion also covers when empirical antibiotic use may be appropriate and how to ensure these decisions are justified.
Each episode offers practical, evidence-based insights which Krka says can be easily implemented in general practice.
The series is accompanied by downloadable Vet2Vet Insights information sheets that summarise the main take-home messages from each episode.
https://open.spotify.com/show/0uphORU03q29WncwmN2EIa
The information sheets are available here: https://www.krka.co.uk/veterinary-knowledge-hub/articles/responsible-use-of-companion-animal-antibiotics
Topics include the pathogenesis of OA, the importance of personalised treatment plans, and practical tips for supporting both pets and caregivers.
The first podcast centres around understanding the pathogenesis of the condition and the importance of thorough clinical examinations, diagnostic imaging and early intervention, all of which can greatly influence long-term outcomes.
Stuart said: “We often see pain as a problem, but it’s also a signal that gives us the opportunity to act early and prevent further progression.
"By the time pain is obvious, the disease is often so advanced that our ability to make a meaningful impact is limited.
"Acting early can change this pattern, and that’s a critical message we need to communicate to pet owners.”
Stuart is joined in the series by Krka’s technical veterinary adviser, Renzo Di Florio.
In subsequent episodes they share their thoughts on the latest advances in osteoarthritis treatment, creating an effective management plan that is individualised for each patient and tips for engaging with caregivers.
Renzo said: “Our goal with this podcast series is to empower veterinary professionals - whether they are new graduates or experienced practitioners - with evidence-based knowledge they can trust and apply.
"We’re excited to share these insights and have more planned for 2025, so stay tuned!”
Otomicol contains miconazole nitrate, prednisolone acetate and polymyxin B.
The product targets a range of pathogens including miconazole and polymyxin B-sensitive, Malassezia and Pseudomonas spp.
Renzo Di Florio, technical vet at Krka UK, said: “With its multifactorial aetiology, ear disease is often challenging to manage, causing frustration for owners and significant discomfort for pets.
"Otomicol is a cost-effective solution that veterinary surgeons can add to their treatment toolbox for cases where bacterial and fungal infection are important factors.”
Otomicol ear drops and cutaneous suspension are available in a 15ml bottle with an extended shelf life of six months after opening.
Otomicol is available from veterinary wholesalers.
https://www.krka.co.uk
Reference
The materials include pet owner guides, reception posters and slides to display on waiting room TV.
They complement the Krka veterinary professional guide on responsible risk-based parasiticide use for cats and dogs that was developed in conjunction with Ian Wright BVMS MSc MRCVS and launched last year.
Renzo Di Florio, Krka’s Technical Veterinary Adviser said: “In first opinion veterinary practice, where the majority of consultations last 15 minutes or less, time is short and in-depth discussions are not always possible.
"The guides provide comprehensive information on common parasites, practical advice on prevention and treatment and information on risk assessment.
"And by aligning with ESCCAP guidelines, the guides help address the delicate balance between animal health, human health and environmental protection – a true One Health issue.”
https://www.krka.co.uk/veterinary-knowledge-hub/articles/risk-based-parasiticide-use-for-cats-and-dogs
Robexera is a COX2 NSAID formulation which delivers anti-inflammatory pain relief with a once-a-day dosing regime2,3,4.
The product is presented as a flavoured chewable tablet for easier administration by pet owners.
For simplicity when dispensing, it comes in four strengths with colour coded boxes, perforated blisters and a set of PIL sheets that convert to prescribing envelopes in each pack.
Charlotte Read, Krka’s UK Key Account Manager, said: “Delivering reliable, cost-effective perioperative pain relief for soft tissue surgery is an everyday concern for veterinary practices, while OA is the most common cause of chronic pain in dogs5.
"This is why we’re particularly pleased to announce the first generic robenacoxib, Robexera.
“Bioequivalent to the originator product6, Robexera provides fast-acting and targeted pain relief, giving enhanced value to veterinary practices and enabling them to offer their clients improved affordability, particularly for those whose animals are on long term pain-management programmes or have other health issues.”
Viktor Kozjan, General Manager Krka UK, added: “The launch of Robexera is further confirmation of Krka’s commitment to develop solutions that are tried and trusted but also flexible and affordable for our customers and their clients.”
Robexera is now available to order from all national UK veterinary wholesalers.
Cladaxxa is a combined amoxicillin/clavulanic antibiotic, which Krka says is bioequivalent to the market reference product1,2,3,4.
The new product is available in three strengths of flavoured tablet, with the 200/50 mg formulation also licensed for cats.
Cladaxxa is presented in blister packaging to protect the clavulanic acid, which is highly sensitive to moisture.
The tablets are ready-scored to help with accurate dosing and halved tablets can be returned to the protective blister packaging to be used within the following 24 hours.
Cladaxxa comes in packs of 60 or 100 tablets.
Krka’s National Sales Manager Will Ridgway, said: "Treating bacterial infections is an important everyday task for vets in practice.
"Cladaxxa is a great example of Krka using its expertise in end to end product design to deliver efficacy and value to our customers.”
Krka says Milprazon Chewable is the first wormer in its category with proven palatability for dogs based on EMA Testing Guidelines.
In a study¹, more than 85% of dogs ate the tablet ‘voluntarily’, with 75% taking it unprompted from their food bowl.
Milprazon chewable is available in a range of presentations suitable for puppies from two weeks old (0.5kg) and kittens from six weeks old.
Milprazon comes in colour-coded packaging for easier dispensing.
Will Ridgway, Krka’s National Sales Manager said: "Milprazon Chewable is a premium product.
"It offers pet owners the reliability of Milbemycin oxime and Praziquantel, together with enhanced palatability, while supporting practice profitability."
Flimabend is diluted into water and replaces the flock’s drinking water for a set period during the day.
The new 20g pack includes a post-prescription leaflet to help veterinary surgeons support clients in calculating the correct dose, based on the bodyweight of their flock. It also includes a measuring scoop to ensure accurate administration.
Flimabend is effective against the three key intestinal worms affecting chickens – Ascaridia (roundworm); Capillaria (hairworm) and Heterakis gallinarum, which can be a vector for Blackhead disease. No egg withdrawal period is required.
Charlotte Read, Krka's Key Account Manager – Farm said: “Poultry-rearing is on the increase in the UK, both at a commercial level and among the public. Recent figures suggest that more than one million UK households keep chickens, with the majority of domestic flocks comprising five laying hens and a cockerel1.
"A regular worming routine is, of course, essential for optimal flock health and ensuring ease of use in a worming product is the most effective way of ensuring compliance, especially among those keeping backyard chickens.
“As one of the first water-based worming products available for small flocks, Flimabend now offers an innovative presentation of Flubendazole which we believe offers a new level of convenience and flexibility.”
Krka is currently offering virtual ‘lunch and learns’ on the worming of backyard chickens. Contact your Krka Account Manager for more details.
Ian also discusses the most effective treatment and prevention strategies: "“With surveys showing deworming frequencies below those recommended by ESCCAP and concerns surrounding over treatment of cats and dogs, there has never been a more important time to examine the importance of routine roundworm prevention. Without adequate control of Toxocara canis and Angiostronglyus vasorum, the impact on owners and their pets can be considerable."
The webinar can be viewed here: https://www.elearning.vet/watch/65
According to the company, Prinocate contains the same combination of Moxidectin and Imidacloprid as Advocate. In dogs it is licensed for the treatment and prevention of Angiostrongylus vasorum (lungworm); for the treatment and prevention of fleas and also for lice, mites, heartworm and roundworms. In cats, the licence covers fleas, mites, roundworm and heart worm.
Prinocate is offered in six presentations to suit all weight ranges and in packs of three pipettes, to suit most pet health plans. Each pipette is individually wrapped for ease of use and dispensing.
Krka’s National Veterinary Sales Manager Will Ridgway, said: "Prinocate offers practices and pet owners the reassurance of tried and trusted actives moxidectin and imidacloprid, the reliability of spot-on delivery and the affordability that Krka customers have come to expect.
"Its launch, hot on the heels of Selehold, and added to our wormers Milprazon and Anthelmin, means that Krka now offers an attractive, reliable and affordable parasite control range and, during its launch period, we are offering one free pack of Prinocate for every five purchased.”
He added: “As Angiostrongylus vasorum is one of the main parasites of concern in practice today, to mark the launch of Prinocate, we’re delighted to be offering a free webinar with Ian Wright during which he will explore how A.vasorum has managed to spread so successfully and the most effective preventative protocol to offer your clients.”
The webinar takes place on Tuesday, 2nd June 2020 at 8:00pm. To register, visit: https://tinyurl.com/avasorum
Krka says the new pack, available for cats and for toy, small, medium and large dogs, is designed to offer practices greater dispensing flexibility and to encourage quarterly visits and compliance with healthcare plans.
Selehold is presented in a pipette with a colour-coded cap and transparent tube to enable the owner to check when the full dose has been given. Each pipette is individually wrapped for ease of use and dispensing.
Ms Sabrina Jordan, Country Brand Manager for Krka, said: "We aim to optimise the value we give to our customers by offering them highly effective, tried and trusted, affordable generic medicines with added value.
"Selehold has proved a popular addition to our parasite control range because of its ease of use and cost-effectiveness.
"With many of our customers focusing on encouraging owners to visit the practice quarterly and to sign up to a healthcare plan for their pet, the 3-pack version of Selehold works well as it enables the practice to offer clients a high quality, good value solution that supports this compliance framework."
Two winners will be flown from a London airport to spend 2 nights at the Krka Terme Hotel Svoboda Strunjan, a night at the Grand Union Hotel Ljubljana and a night at the Grand Hotel Bled, plus car hire.
To enter, visit www.discoverkrka.co.uk and pick out the differences between the Dalmations.
Ned Flaxman from Krka said: "I’ve only recently joined KRKA and I’m sure like many people I imagined Slovenia to be some far-off country in Eastern Europe. But it’s much closer than you might think - being only a couple hour’s boat ride from Venice.
"I would urge anyone to enter the competition to be in with the chance of winning this truly memorable trip. From the cliffs and stunning beaches of Strunjan to the lively and beautiful city of Ljubljana, Slovenia is a hidden gem just waiting to be discovered."
Amflee Combo, a POM, is being launched by a newcomer to the UK market, a Slovenian company called Krka (pronounced kirka). The company says it plans to introduce a vast range of small and production animal products onto the UK market in the next few years.
Killian Gaffney, Head of sales and marketing at Krka, says the company intends to support UK veterinary surgeons by offering high quality products and by building business relationships that will help protect veterinary incomes, at the same time as offering good value to their customers.
Killian said: "Amflee Combo has some unique features that we believe will set it apart from the competition. We know the combination of the two active ingredients in Amflee Combo is very effective for the treatment of fleas, ticks and biting lice and as part of a treatment strategy for flea allergy dermatitis in dogs and cats. S-methoprene is also effective against flea eggs and larvae in the environment.
"However, these ingredients can be susceptible to degradation when subjected to light and moisture, which is why each Amflee Combo pipette comes in its own special foil wrapper. The pipettes have also been designed for convenience of use, since we know that only 22% of owners apply spot-ons correctly1."
A range of product and client literature to support the use of Amflee Combo is available by calling 01753 722 150.
Amflee Combo is available in a variety of packs for cats and different sized dogs, containing either three or six pipettes. The recommended treatment is one pipette every four weeks.
Further information about Amflee Combo or Krka is available at www.krka.co.uk
1 El veterinario ante el cambio climatico Argos 107, 2010.